The Acquisition is being carried out pursuant to the terms of a claims purchase agreement dated
As consideration for the Acquisition, the Company has issued 100,000 common shares in the capital of the Company at a deemed price of
The Acquisition remains subject to receipt of all necessary regulatory and other approvals, including final approval of the
About
Contact:
Tel: (416) 707-4230
Notice Regarding Forward-Looking Information
Certain information set forth in this news release may contain forward-looking information that involves substantial known and unknown risks and uncertainties. This forward-looking information is subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including, but not limited to, the impact of general economic conditions, industry conditions, dependence upon regulatory approvals, and commodity prices. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking information. The parties undertake no obligation to update forward-looking information except as otherwise may be required by applicable securities law.
(C) 2021 Electronic News Publishing, source